"The
Report Sepsis - Pipeline Review, H2 2016 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
Global Markets Directs, Sepsis
- Pipeline Review, H2 2016,
provides an overview of the Sepsis pipeline landscape.
The report provides
comprehensive information on the therapeutics under development for
Sepsis, complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type. The report also covers the descriptive pharmacological action
of the therapeutics, its complete research and development history
and latest news and press releases. Additionally, the report provides
an overview of key players involved in therapeutic development for
Sepsis and features dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/785493
Scope
- The report provides a
snapshot of the global therapeutic landscape of Sepsis
- The report reviews pipeline
therapeutics for Sepsis by companies and universities/research
institutes based on information derived from company and
industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved Sepsis therapeutics and enlists all their major and
minor projects
- The report assesses Sepsis
therapeutics based on drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news related to pipeline therapeutics for Sepsis
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Sepsis
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding Sepsis pipeline depth and
focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic
portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Table
of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report
Coverage 10
Sepsis Overview 11
Therapeutics Development 12
Pipeline Products for Sepsis -
Overview 12
Pipeline Products for Sepsis -
Comparative Analysis 13
Sepsis - Therapeutics under
Development by Companies 14
Sepsis - Therapeutics under
Investigation by Universities/Institutes 19
Sepsis - Pipeline Products
Glance 21
Late Stage Products 21
Clinical Stage Products 22
Early Stage Products 23
Unknown Stage Products 24
Sepsis - Products under
Development by Companies 25
Sepsis - Products under
Investigation by Universities/Institutes 30
Sepsis - Companies Involved in
Therapeutics Development 31
Adrenomed AG 31
Altor BioScience Corporation 32
Am-Pharma B.V. 33
Arch Biopartners, Inc. 34
Aridis Pharmaceuticals LLC 35
Asahi Kasei Pharma Corp. 36
Astellas Pharma Inc. 37
Batu Biologics, Inc. 38
Biomedica Management
Corporation 39
Boehringer Ingelheim GmbH 40
Bristol-Myers Squibb Company 41
Cell2B S.A. 42
Chiesi Farmaceutici SpA 43
Chiome Bioscience, Inc. 44
Cilian AG 45
Cognosci, Inc. 46
Cytheris SA 47
Endacea, Inc. 48
Evec, Inc. 49
Huons Co., Ltd. 50
Immune Response BioPharma, Inc.
51
Immunethep, SA 52
ImmunNovative Developments SL
53
InflaRx GmbH 54
Inotrem S.A. 55
Integrated BioTherapeutics,
Inc. 56
Lead Discovery Center GmbH 57
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment